Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Authors :: Jiménez-Ubieto A
Martín-Muñoz A
Poza M
Dorado S
García-Ortiz A
Revilla E
Sarandeses P
Ruiz-Heredia Y
Baumann T
Rodríguez A
Calbacho M
Sánchez PM
Pina JMS
García-Sancho AM
Figaredo G
Gil-Alós D
Rufián L
Rodríguez M
Carneros L
Martínez-Laperche C
Bastos-Oreiro M
Wang C
Cedena MT
Rapado I
de Toledo P
Gallardo M
Valeri A
Ayala R
Martínez-López J
Barrio S
Source :: Frontiers in immunology [Front Immunol] 2024 Jan 10; Vol. 14, pp. 1349296. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2023).
Publication Year :: 2024
Abstract: [This corrects the article DOI: 10.3389/fimmu.2023.1188818.].<br /> (Copyright © 2024 Jiménez-Ubieto, Martín-Muñoz, Poza, Dorado, García-Ortiz, Revilla, Sarandeses, Ruiz-Heredia, Baumann, Rodríguez, Calbacho, Sánchez, Pina, García-Sancho, Figaredo, Gil-Alós, Rufián, Rodríguez, Carneros, Martínez-Laperche, Bastos-Oreiro, Wang, Cedena, Rapado, de Toledo, Gallardo, Valeri, Ayala, Martínez-López and Barrio.)

Full Text Access

Tools